Published in Clin Dev Immunol on June 01, 2004
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun (2008) 2.50
Increased IgG4 levels in children with autism disorder. Brain Behav Immun (2008) 1.32
Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics (2008) 1.27
Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder. Transl Psychiatry (2013) 1.17
Impact of innate immunity in a subset of children with autism spectrum disorders: a case control study. J Neuroinflammation (2008) 1.14
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Mol Neurosci (2013) 1.04
Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial. Psychopharmacology (Berl) (2012) 1.03
Autism and increased paternal age related changes in global levels of gene expression regulation. PLoS One (2011) 1.03
Parental autoimmune diseases associated with autism spectrum disorders in offspring. Epidemiology (2010) 1.03
Association of a MET genetic variant with autism-associated maternal autoantibodies to fetal brain proteins and cytokine expression. Transl Psychiatry (2011) 1.02
Autism, asthma, inflammation, and the hygiene hypothesis. Med Hypotheses (2007) 1.02
The promise and the pitfalls of autism research: an introductory note for new autism researchers. Brain Res (2010) 0.99
The multi-systemic nature of diabetes mellitus: Genotype or phenotype? N Am J Med Sci (2010) 0.99
Associations of HLA alleles with specific language impairment. J Neurodev Disord (2014) 0.95
Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Mol Autism (2011) 0.94
Epigenomic strategies at the interface of genetic and environmental risk factors for autism. J Hum Genet (2013) 0.90
Animal models of autism spectrum disorders: information for neurotoxicologists. Neurotoxicology (2009) 0.86
Increased serum levels of epidermal growth factor in children with autism. J Autism Dev Disord (2011) 0.83
Low serum IgA and increased expression of CD23 on B lymphocytes in peripheral blood in children with regressive autism aged 3-6 years old. Arch Med Sci (2012) 0.83
Hyperbaric oxygen treatment in autism spectrum disorders. Med Gas Res (2012) 0.81
Autoimmunity, Autoantibodies, and Autism Spectrum Disorder. Biol Psychiatry (2016) 0.78
Brief report: Hyperbaric oxygen therapy (HBOT) in children with autism spectrum disorder: a clinical trial. J Autism Dev Disord (2012) 0.78
Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice. PLoS One (2012) 0.76
Pathogenesis of autism: a patchwork of genetic causes. Future Neurol (2009) 0.76
Significant Association of HLA-B Alleles and Genotypes in Thai Children with Autism Spectrum Disorders: A Case-Control Study. Dis Markers (2015) 0.76
What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature? N Am J Med Sci (2009) 0.75
Beyond infection - Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol (2017) 0.75
The immune response in autism: a new frontier for autism research. J Leukoc Biol (2006) 2.65
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun (2008) 2.50
Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav Immun (2010) 2.44
Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells. J Exp Med (2002) 2.00
Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology (2007) 1.87
Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med (2005) 1.81
Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis. J Clin Invest (2002) 1.65
Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci (2007) 1.55
Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology (2009) 1.55
Maternal mid-pregnancy autoantibodies to fetal brain protein: the early markers for autism study. Biol Psychiatry (2008) 1.54
Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. Hepatology (2010) 1.53
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Mol Autism (2011) 1.51
Ultra Low Density and Highly Crosslinked Biocompatible Shape Memory Polyurethane Foams. J Polym Sci B Polym Phys (2012) 1.48
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol (2010) 1.46
Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol (2008) 1.41
Is autism an autoimmune disease? Autoimmun Rev (2004) 1.37
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res (2008) 1.37
Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun (2008) 1.34
The immune system's role in the biology of autism. Curr Opin Neurol (2010) 1.31
Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics (2010) 1.22
Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol (2003) 1.21
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Genetic and immunologic considerations in autism. Neurobiol Dis (2002) 1.19
Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci (2007) 1.11
Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders. J Neuroimmunol (2009) 1.11
Behavioral correlates of maternal antibody status among children with autism. J Autism Dev Disord (2012) 1.11
Maternal autoantibodies in autism. Arch Neurol (2012) 1.08
Autoantibodies to cerebellum in children with autism associate with behavior. Brain Behav Immun (2010) 1.07
In search of cellular immunophenotypes in the blood of children with autism. PLoS One (2011) 1.04
Immune-mediated disorders among women carriers of fragile X premutation alleles. Am J Med Genet A (2012) 1.04
Identifying environmental contributions to autism: provocative clues and false leads. Ment Retard Dev Disabil Res Rev (2004) 1.00
Maternal autism-associated IgG antibodies delay development and produce anxiety in a mouse gestational transfer model. J Neuroimmunol (2012) 0.98
Polyurethane shape-memory polymers demonstrate functional biocompatibility in vitro. Macromol Biosci (2007) 0.98
Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev (2002) 0.96
Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder. Brain Behav Immun (2013) 0.95
Brain-derived neurotrophic factor and autism: maternal and infant peripheral blood levels in the Early Markers for Autism (EMA) Study. Autism Res (2008) 0.93
Correlations of gene expression with blood lead levels in children with autism compared to typically developing controls. Neurotox Res (2009) 0.93
Brief report: plasma leptin levels are elevated in autism: association with early onset phenotype? J Autism Dev Disord (2007) 0.93
Increased anti-phospholipid antibodies in autism spectrum disorders. Mediators Inflamm (2013) 0.92
Maternal immune-mediated conditions, autism spectrum disorders, and developmental delay. J Autism Dev Disord (2014) 0.91
B cells in autoimmune diseases: insights from analyses of immunoglobulin variable (Ig V) gene usage. Autoimmun Rev (2007) 0.90
Detection of plasma autoantibodies to brain tissue in young children with and without autism spectrum disorders. Brain Behav Immun (2011) 0.88
Elevated expression of tyrosine kinase DDR2 in primary biliary cirrhosis. Autoimmunity (2002) 0.86
Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology (2003) 0.86
Maternal and fetal antibrain antibodies in development and disease. Dev Neurobiol (2012) 0.86
Correlations between gene expression and mercury levels in blood of boys with and without autism. Neurotox Res (2009) 0.84
Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study. J Neuroinflammation (2014) 0.84
Decreased levels of EGF in plasma of children with autism spectrum disorder. Autism Res Treat (2012) 0.83
Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J Neuroimmunol (2009) 0.83
Decreased levels of total immunoglobulin in children with autism are not a result of B cell dysfunction. J Neuroimmunol (2012) 0.82
Analysis of TCR antagonism and molecular mimicry of an HLA-A0201-restricted CTL epitope in primary biliary cirrhosis. Hepatology (2002) 0.81
Women and primary biliary cirrhosis. Clin Rev Allergy Immunol (2015) 0.81
Proteasome is required for class I-restricted presentation by Fcgamma receptor-mediated endocytosis in primary biliary cirrhosis. J Autoimmun (2003) 0.79
Brief Report: Antibodies Reacting to Brain Tissue in Basque Spanish Children with Autism Spectrum Disorder and Their Mothers. J Autism Dev Disord (2013) 0.77
Group I metabotropic glutamate receptor mediated dynamic immune dysfunction in children with fragile X syndrome. J Neuroinflammation (2014) 0.76
Autism: where genetics meets the immune system. Autism Res Treat (2012) 0.75
Oral tolerance and pyruvate dehydrogenase in patients with primary biliary cirrhosis. Dev Immunol (2002) 0.75